News

A recent study has found that omalizumab, a medication commonly used to treat asthma, may also be beneficial for people with multiple food allergies. The study involved 118 participants who received omalizumab injections every two to four weeks for four…

The European Food Safety Authority (EFSA) has designed and developed a software tool that can assess the risk of novel proteins for people with coeliac disease.   People with coeliac disease are known to have either one or two receptor molecules—HLA-DQ2…

Quantitative gluten testing must usually be carried out in a laboratory setting due to the use of technical equipment and reagents. Responding to a need for more simple and affordable methods, researchers have developed a gluten-sensitive colour-changing biosensor.   The biosensor…

While 1-2 per cent of the Australian population has been diagnosed with coeliac disease or wheat allergy, around 10 per cent report having non-coeliac gluten sensitivity, a condition that remains controversial due to the lack of scientific understanding of the…

Advanced glycation end-products (AGEs) are compounds formed during food processing. They have previously been implicated in the development of childhood food allergies, and their potential role has become clearer thanks to new research.   A group in Italy has demonstrated that…

Omalizumab, a medication approved in many countries for the treatment of asthma and hives, has shown potential in protecting against anaphylactic reactions in people with severe food allergies.   Early results from a large clinical trial in the US indicate that…